Matthew Booth

Matthew Booth has a diverse work experience spanning over twenty years. Currently, they serve as the SVP, Global Therapy Lead at MEDiSTRAVA, an Inizio Company, since October 2021. Prior to this role, they worked as the Global Practice Lead at MEDiSTRAVA from March 2020 to September 2021.

Before joining MEDiSTRAVA, Matthew held various positions at PAREXEL. Matthew worked as the Senior Director of Scientific Services from March 2018 to June 2020 and as the Director of Scientific Services from January 2014 to March 2018. Additionally, they served as a Scientific Team Leader from March 2013 to December 2013.

Matthew's work experience also includes roles at ApotheCom ScopeMedical - A Huntsworth Health Company, where they worked as a Senior Account Manager from August 2011 to March 2013, and as a Senior Medical Writer at ApotheCom ScopeMedical from October 2009 to July 2011.

Prior to that, Matthew worked as a Medical Writer at Zaicom International from June 2007 to October 2009 and as a Senior Scientist at BioVex Inc. from June 2006 to April 2007.

Before transitioning to industry, Matthew gained research experience at University College London. Matthew worked as a Senior Postdoctoral Research Scientist from June 2003 to June 2006 and as a Postdoctoral Research Scientist from October 2000 to June 2003.

Matthew Booth received their PhD in Biochemistry from Imperial College London, where they studied from 1996 to 2000. No further education history is available.